Satellite Symposia

Who Can Attend Satellite Symposia?

These are open to all in-person attendees at ATC 2026 and there is no separate registration fee to attend.

Date	Time	Symposia Supported By	Room Number	Session Topic	Session Description
Sunday, June 21	7:00 - 8:00 AM	Nexus Healthcare Education	156ABC Thomas M. Menino Convention & Exhibition Center	Individualized Immunosuppression in Renal Transplant: Evidence, Strategies, & Best Practices RSVP	Join leading experts for a dynamic, case-based symposium focused on advancing individualized immunosuppression strategies in renal transplant. Explore current maintenance regimens, including calcineurin inhibitors, mTOR inhibitors, belatacept, and antimetabolites, while evaluating their efficacy, safety, and long-term outcomes. Delve into conversion strategies for patients experiencing therapy failures, and examine emerging immunosuppression therapies, including novel combinations and investigational approaches shaping the future of transplant care. Engage with a multidisciplinary expert panel to discuss practical applications, patient-centered decision-making, and strategies to optimize long-term safety, adherence, and quality of life for renal transplant recipients. Speakers: Deidre Sawinski Gurav Gupta David Wojchiechowski Tarek Alhamad
Sunday, June 21	12:15 - 1:15 PM	Natera	156ABC Thomas M. Menino Convention & Exhibition Center	Cell-Free DNA: From Promise to Practice—How Far We’ve Come	Join us for a journey through the evolution of donor-derived cell-free DNA (dd-cfDNA). From early research to today’s standard of care. Featuring expert perspectives this session bridges the gap between clinical data and real-world practice. Discover how current dd-cfDNA utilization strategies and future molecular frontiers are empowering clinicians to detect rejection earlier and improve long-term patient outcomes. Speakers Phil Gauthier, MD, MBA Zahraa Hajjiri, MD Emilio Poggio, MD Yasir Qazi, MD
Sunday, June 21	12:15 - 1:15 PM	Eledon Pharmaceuticals, Inc.	157ABC Thomas M. Menino Convention & Exhibition Center	The Hidden Burden of Transplant Success: The Impact of Lifelong Immunosuppression in Organ Transplantation — Risks, Trade-offs, and Emerging Solutions RSVP	Join transplant physicians and transplant patients at ATC for an industry sponsored symposium: “The Hidden Burden of Transplant Success: The impact of lifelong immunosuppression in Organ Transplantation: Risks, Trade-offs, and Emerging Solutions”. Sunday, June 21, 2026, 12:15–1:15 PM. Through panel discussion and shared clinical and patient perspectives, this symposium will examine the quality-of-life impact of CNIs and other immunosuppressive therapies, highlighting real-world experiences and the ongoing unmet needs in post-transplant care.
Sunday, June 21	12:15 - 1:15 PM	CareDx	210BC Thomas M. Menino Convention & Exhibition Center	From Signal to Strategy: Translating AlloSure Molecular Insights into Confident Clinical Decisions	Join CareDx for an interactive symposium featuring real-world patient case examples, including novel use of AlloSure Kidney, landmark data from KOAR, and innovative clinical scenarios. Speakers: David Wojciechowski, MD Nicole Ali, MD Dierdre Sawinski, MD Nicolae Leca, MD
Sunday, June 21	12:15 - 1:15 PM	Merck & Co.	252AB Thomas M. Menino Convention & Exhibition Center	Considerations for CMV disease prevention in kidney transplantation	Discuss the burden of CMV infection and disease in kidney transplantation Review AST guideline (2019) recommendations for CMV prevention in adult kidney transplant patients. Review clinical data for an option to help prevent CMV disease in high-risk adult kidney transplant recipients. Speakers Vinayak Rohan, MD
Monday, June 22	7:00 - 8:00 AM	Bridge to Life	156ABC Thomas M. Menino Convention & Exhibition Center	The Next Era of Machine Perfusion: From Evidence to Adoption in Clinical Practice	This session examines the next phase of machine perfusion in liver transplantation by connecting clinical evidence with real-world implementation in the U.S. post-commercialization setting. It reviews insights from the Bridge to HOPE trial and the clinical and mechanistic rationale for hypothermic oxygenated perfusion (HOPE). It will then explore how viability assessment during hypothermia is evolving from descriptive observation to objective decision-making, and conclude with a discussion of the economic and operational realities of implementing perfusion. Speakers: Andrea Schlegel David Foley Iam Jamieson
Monday, June 22	12:15 - 1:15 PM	TransMedics	156ABC Thomas M. Menino Convention & Exhibition Center	The OCS™ Revolution: How TransMedics Transformed Liver Transplantation — and Is Pioneering the Future of Kidney Preservation	This year at ATC, we are excited to share with you our continuing success with the OCS™ Liver after performing more than 11,000 liver transplants with excellent outcomes since the FDA approval. We are also thrilled to share with you an early glimpse at our novel OCS™ Kidney, now in development. It represents the start of our next-generation OCS™ 3 technology.
Monday, June 22	12:15 - 1:15 PM	RMEI Medical Education LLC (Takeda)	157ABC Thomas M. Menino Convention & Exhibition Center	Targeted Approaches to CMV Management: Alleviating the Patient Burden from Prevention to Refractory Disease RSVP	Cytomegalovirus (CMV) can be a life-altering reality for patients after solid organ transplant (SOT). Limited antivirals and rising resistance make treatment a challenge. Join Drs. Deepali Kumar and Raymund R. Razonable as they share practical, evidence-based strategies to tackle the most common serious infectious complication after SOT. The faculty will be joined by a patient who will speak directly about how her transplant journey was complicated by CMV and what it means for her to navigate this challenging infection on her path towards healing.
Monday, June 22	12:15 - 1:15 PM	Paragonix Technologies	210BC Thomas M. Menino Convention & Exhibition Center	Breaking Boundaries: Next-Generation Approaches to Abdominal Preservation RSVP	Join leading clinical experts for a focused exploration of how advanced preservation strategies are transforming abdominal transplantation. This session will highlight the latest scientific and technological innovations shaping modern preservation and transport, and how they are redefining long-standing standards of care. Attendees will gain insight into how next-generation approaches to preservation are improving organ quality, expanding utilization, and driving better outcomes.
Monday, June 22	12:15 - 1:15 PM	Hansa Biopharma	Harbor Ballroom 1 The Westin Boston Seaport	The Highly Sensitized Patient: Prioritized and Still Waiting	Despite the increase in the transplantation rate after KAS implementation and the maturation of KPD programs, many highly sensitized candidates have disproportionately long waiting time. Even in the current era, highly sensitized are more likely to be removed from the waitlist, die, or remain wait-listed than receive a transplant within a reasonable timeframe.¹ Join the experts as they define the unmet needs of highly sensitized patients and discuss potential opportunities to help reduce barriers to kidney transplantation. ¹Schinstock, CA et al. Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: is there still a role for desensitization? Clin Transplant. 2019; 33: e13751 Speakers: Ashley Vo, PharmD, FAST Bonnie Lonze, MD, PhD Matthew Cooper, MD
Monday, June 22	12:15 - 1:15 PM	Sanofi	Harbor Ballroom 2 & 3 The Westin Boston Seaport	The Drop in Deceased Donor Kidney Transplants: Causes, Consequences, and Considerations	The session reviews evidence, policy impacts, and innovative strategies for the efficient and equitable use of challenging kidneys which can help lead to maximal life-saving benefit. Join us as we explore the causes and consequences of the recent decline in U.S. deceased donor kidney transplants.
Tuesday, June 23	12:15 - 1:15 PM	Biogen	156ABC Thomas M. Menino Convention & Exhibition Center	Advancements in Antibody Mediated Rejection and Microvascular Inflammation of Kidney Allograft: Biology, Biomarkers, and Beyond	Antibody mediated rejection (AMR) is a leading cause of kidney allograft failure, with no approved therapies and limited evidence based treatment guidance. Advancing AMR care requires improved understanding of disease biology, early and accurate detection, and more targeted therapeutic strategies. This symposium examines the roles of CD38 expressing immune cells in AMR and microvascular inflammation, reviews emerging biomarkers for patient identification, monitoring, and treatment response, and discusses evolving CD38 targeted investigational approaches.
Tuesday, June 23	12:15 - 1:15 PM	Thermo Fisher Scientific	252AB Thomas M. Menino Convention & Exhibition Center	Biopsy to Biomarkers: A Multimodal View of Kidney Transplant Assessment	Join us for a multidisciplinary discussion on kidney transplant assessment, from traditional biopsy to advanced biomarker approaches. This symposium will highlight MMDx™ Kidney data, along with emerging tools such as CXCL10, a protein biomarker, and TacroType™, a genotyping test that assesses CYP3A5 variation that may impact tacrolimus metabolism. Learn how these tools may be used to support transplant patient assessments. Speakers: Alex Rogers, PharmD Keith Melancon, MD Gaurav Gupta, MD
Tuesday, June 23	12:15 - 1:15 PM	Veloxis Pharmaceuticals	Harbor Ballroom 2 & 3 The Westin Boston Seaport	From Reflection to Action: Adjusting Immunosuppressive Therapy to Overcome Long-Term Therapeutic Inertia in Kidney Transplantation RSVP	Kidney transplantation is currently the gold standard of care and provides patients with end-stage kidney disease the best chance for long-term, dialysis-free survival, but, in addition to challenges regarding organ availability, is the challenge of optimizing allograft survival over time. In this live event, the audience will have an opportunity to connect with their colleagues and experts to discuss real- world situations that can present challenges, complications, and decision points that may arise in the management of kidney transplant recipients.